FDA approves Teva's generic nasal spray to treat opioid overdose

19 april 2019 | Bron: Reuters Health

Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said.

Lees verder op: Reuters Health